<DOC>
	<DOCNO>NCT00469183</DOCNO>
	<brief_summary>Evaluate atrophogenic potential long-term use Tri-Luma Cream facial Melasma biopsy examination .</brief_summary>
	<brief_title>Assessment Atrophogenic Potential Triple Combination Cream Treatment Melasma</brief_title>
	<detailed_description>Same .</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<mesh_term>Hydroquinone</mesh_term>
	<criteria>Subjects must clinical diagnosis moderate severe melasma Subjects willing undergo biopsy four time throughout study , two biopsy baseline ( one melasma involve area one noninvolved area ) . The third fourth biopsy perform 3 month 6 month , respectively ; order avoid variability histopathological finding , Subjects must substantial melasma involvement cheek willing general site biopsied baseline , month 3 month 6 visit . Subjects diagnosis dermal melasma Subjects foresee intensive UV exposure study ( mountain sport , UV radiation , sunbathe , etc . ) Subjects used retinoids , steroid , and/or skin lightening product 4 week prior study entry Subjects show sign Poikiloderma Civatte ( mandibular hyperpigmentation ) Subjects history hypertrophic scar history keloid Subjects unable avoid use class 1 steroid participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>